Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Gossamer Bio, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 133 | 141 | +8 |
| Shares | 58.8M | 59.9M | +1.07M (+1.8%) |
| Value | $664.9M | $519.8M | −$145.1M (−21.8%) |
New holders (25)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (17)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 683,000 | $7.72M |
| Lord, Abbett & Co. LLC | 390,146 | $4.41M |
| Acuta Capital Partners, LLC | 119,843 | $1.35M |
| Moore Capital Management, LP | 109,024 | $1.23M |
| Barclays PLC | 72,450 | $819.0K |
| Public Employees Retirement System of Ohio | 70,332 | $795.0K |
| Ergoteles LLC | 40,316 | $456.0K |
| Gyon Technologies Capital Management, LP | 34,222 | $387.0K |
| XTX Topco Ltd | 13,310 | $151.0K |
| Belvedere Trading LLC | 14,089 | $145.0K |
| Texas Yale Capital Corp. | 10,000 | $113.0K |
| Walleye Trading LLC | 7,282 | $82.0K |
| US Bancorp | 1,500 | $17.0K |
| TCI Wealth Advisors, Inc. | 397 | $4.00K |
| The PNC Financial Services Group, Inc. | 200 | $2.00K |
| Aspire Private Capital, LLC | 200 | $2.00K |
| Bivin & Associates, Inc. | 70 | $1.00K |